Next Gen Diagnostics
Next Gen Diagnostics (NGD) is dedicated to transforming microbiology diagnostics and infection control through automated, low-cost sequencing and bioinformatics solutions. Founded in 2017 in Cambridge, UK, NGD combines advanced automation with powerful bioinformatics tools to enable real-time outbreak prevention, diagnostics, and resistance mechanism discovery for healthcare, public health, and pharmaceutical sectors. The company offers integrated sequencing services, develops machine learning models for antibiotic susceptibility prediction, and collaborates with various industry and academic partners to advance pathogen genomics and infection control.
Industries
Nr. of Employees
small (1-50)
Products
Microfluidic sample-preparation instrument
Microfluidic instrument and associated reagent workflows for automated pathogen sample preparation to feed high-throughput WGS pipelines, reducing cost and hands-on time.
Microfluidic sample-preparation instrument
Microfluidic instrument and associated reagent workflows for automated pathogen sample preparation to feed high-throughput WGS pipelines, reducing cost and hands-on time.
Services
On-site end-to-end sequencing and infection control service
Deployment of an on-site service that includes automated sample preparation, sequencing and automated bioinformatic analysis delivered with training and consumables to enable rapid transmission detection and outbreak prevention.
Sequence-based diagnostic and ML model collaboration for pharma
Collaborative development and validation of sequence-based diagnostics and machine-learning models to predict antibiotic susceptibility and to investigate resistance mechanisms for drug development and clinical research.
Sequencing and bioinformatics laboratory services
Operational sequencing and bioinformatics services provided from established laboratory locations to support prospective surveillance, research consortia and clinical projects.
On-site end-to-end sequencing and infection control service
Deployment of an on-site service that includes automated sample preparation, sequencing and automated bioinformatic analysis delivered with training and consumables to enable rapid transmission detection and outbreak prevention.
Sequence-based diagnostic and ML model collaboration for pharma
Collaborative development and validation of sequence-based diagnostics and machine-learning models to predict antibiotic susceptibility and to investigate resistance mechanisms for drug development and clinical research.
Sequencing and bioinformatics laboratory services
Operational sequencing and bioinformatics services provided from established laboratory locations to support prospective surveillance, research consortia and clinical projects.
Expertise Areas
- Pathogen whole-genome sequencing for outbreak detection
- Clinical infectious disease genomics and infection prevention
- Genomic epidemiology and SNP-level transmission analysis
- Machine learning models for antibiotic susceptibility prediction
Key Technologies
- Whole-genome sequencing (WGS)
- Automated microfluidic sample preparation
- High-throughput sequencing workflows
- Automated bioinformatics pipelines